Article Information
History
- May 14, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 14, 2021 - 11:36).
- Version 2 (May 28, 2021 - 08:19).
- Version 3 (June 19, 2021 - 14:31).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sumathi Sivapalasingam, M.D.1,†,*,
- David J. Lederer, M.D., M.S.1,*,
- Rafia Bhore, Ph.D.1,
- Negin Hajizadeh, M.D., M.P.H.2,
- Gerard Criner, M.D., F.A.C.P., F.A.C.C.P3,
- Romana Hossain, M.D., M.P.H.1,‡,
- Adnan Mahmood, M.D.1,
- Angeliki Giannelou, M.D.1,
- Selin Somersan-Karakaya, M.D.1,
- Meagan O’Brien, M.D.1,
- Anita Boyapati, Ph.D.1,
- Janie Parrino, M.D.1,
- Bret Musser, Ph.D.1,
- Emily Labriola-Tompkins, B.A.1,
- Divya Ramesh, Ph.D.1,
- Lisa A. Purcell, Ph.D.1,‡,
- Daya Gulabani, M.S., M.B.A.1,
- Wendy Kampman, M.D.1,
- Alpana Waldron, M.S.1,
- Michelle Ng Gong, M.D.4,
- Suraj Saggar, D.O.5,
- Steven J. Sperber, M.D., F.A.C.P., F.I.D.S.A.6,
- Vidya Menon, M.D., F.A.C.P.7,
- David K. Stein, M.D., F.A.C.P.8,
- Magdalena E. Sobieszczyk, M.D., M.P.H.9,
- William Park, M.D.10,
- Judith A. Aberg, M.D.11,
- Samuel M. Brown, M.D., M.S.12,
- Jack A. Kosmicki, Ph.D.1,
- Julie E. Horowitz, Ph.D.1,
- Manuel A. Ferreira, Ph.D.1,
- Aris Baras, M.D., M.B.A.1,
- Bari Kowal, M.S.1,
- A. Thomas DiCioccio, Ph.D.1,
- Bolanle Akinlade, M.D., M.B.A., F.A.C.P.1,
- Michael C. Nivens, Ph.D.1,
- Ned Braunstein, M.D.1,
- Gary Herman, M.D.1,
- George D. Yancopoulos, M.D., Ph.D.1,
- David M. Weinreich, M.D.1,
- for the Sarilumab-COVID-19 Study Team
- 1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
- 2Institute for Clinical Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York
- 3Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
- 4Montefiore – Moses, Bronx, New York
- 5Holy Name Medical Center, Teaneck, New Jersey
- 6Hackensack Meridian School of Medicine and Hackensack University Medical Center, Hackensack, New Jersey
- 7NYC Health + Hospitals/Lincoln, Bronx, New York
- 8Jacobi Medical Center, Bronx, New York
- 9Columbia University, New York, New York
- 10Pulmonary and Sleep Disorder Clinic, Valley Medical Center, Renton, Washington
- 11Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York
- 12Intermountain Medical Center and University of Utah, Salt Lake City, Utah
- ↵†Corresponding author: Sumathi Sivapalasingam, M.D., Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY 10591, Phone: 914-336-0441; Email: sumathi.sivapalasingam{at}regeneron.com, Target journal: NEJM
↵* Contributed equally